Psoriasis News

The FDA has approved subcutaneous and IV formulations of the Stelara biosimilar Otulfi for Crohn’s disease, ulcerative colitis and all other indications approved for the reference product, according to a press release from Fresenius Kabi.

PHILADELPHIA — Members of the psoriatic disease community recently gathered at the Philadelphia Zoo to raise funds that will be used to support patients through research and advocacy.

SAN DIEGO — New imaging technologies, and improved use of the ones currently available, may move rheumatology closer to precision medicine in inflammatory arthritis, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

The FDA has accepted Arcutis Biotherapeutics’ supplemental new drug application for Zoryve foam 0.3% for the treatment of scalp and body psoriasis in adults and adolescents aged 12 years and older, the company announced in a press release.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release.

Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.

The National Psoriasis Foundation has announced the honorees for this year’s Commit to Cure Gala, according to a press release.

Veterans experience higher prevalence rates of skin cancer, especially melanoma, and psoriasis compared with nonveterans, according to a study.

Blue-collar workers with psoriatic arthritis demonstrate an increased risk for work disability vs. white-collar workers with the same disease, according to data published in Clinical Rheumatology.